Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
A. Nattermann & Cie. GmbH is a long-standing German pharmaceutical company headquartered in Cologne and a subsidiary of Sanofi. Founded in 1906 by August Nattermann, the company became a pioneer in the field of phytopharmaceuticals and is widely recognized for its development of phospholipid-based medicines. Currently, the Cologne facility operates as a strategic manufacturing and development hub within Sanofi's global network, specializing in the production of oral liquids, solids, and semi-solid dosage forms. The site produces a wide range of well-known brands, including Essentiale and Bronchicum, serving both domestic and international markets. It plays a critical role in Sanofi's Consumer Healthcare division, maintaining high standards of GMP-compliant production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nattermann & Cie..